Arnold MA, Kim Y, Czubryt MP, Phan D, McAnally J, Qi X, Shelton JM, Richardson JA, Bassel-Duby R, Olson EN (2007) MEF2C transcription factor controls chondrocyte hypertrophy and bone development. Dev Cell 12(3):377–389
PubMed
Article
CAS
Google Scholar
Barbosa AC, Kim M-S, Ertunc M, Adachi M, Nelson ED, McAnally J, McAnally J, Richardson JA, Kavalali ET, Monteggia LM, Rhonda B-D, Olson EN (2008) MEF2C, a transcription factor that facilitates learning and memory by negative regulation of synapse numbers and function. Proc Natl Acad Sci USA 105(27):9391–9396
PubMed
Article
CAS
Google Scholar
Black BL, Ligon KL, Zhang Y, Olson EN (1996) Cooperative transcriptional activation by the neurogenic basic helix-loop-helix protein MASH1 and members of the myocyte enhancer factor-2 (MEF2) family. J Biol Chem 271(43):26659–26663
PubMed
Article
CAS
Google Scholar
Dron M, Meritet JF, Dandoy-Dron F, Meyniel J-P, Maury C, Tovey MG (2002) Molecular cloning of ADIR, a novel interferon responsive gene encoding a protein related to the torsins. Genomics 79(3):315–325
PubMed
Article
CAS
Google Scholar
Flavell SW, Cowan CW, Kim T-K, Greer PL, Lin Y, Paradis S, Griffith EC, Hu LS, Chen C, Greenberg ME (2006) Activity-dependent regulation of MEF2 transcription factors suppresses excitatory synapse number. Science 311(5763):1008–1012
PubMed
Article
CAS
Google Scholar
Gill G (2003) Post-translational modification by the small ubiquitin-related modifier SUMO has big effects on transcription factor activity. Curr Opin Genet Dev 13(2):108–113
PubMed
Article
CAS
Google Scholar
Hakim NHA, Kounishi T, Alam AHMK, Tsukahara T, Suzuki H (2010) Alternative splicing of Mef2c promoted by Fox-1 during neural differentiation in P19 cells. Genes Cells 15:255–267
Article
Google Scholar
Heidenreich KA, Linseman DA (2004) Myocyte enhancer factor-2 transcription factors in neuronal differentiation and survival. Mol Neurobiol 29(2):155–166
PubMed
Article
CAS
Google Scholar
Ieda M, Fu J-D, Delgado-Olguin P, Vedantham V, Hayashi Y, Bruneau BG, Srivastava D (2010) Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 142(3):375–386
PubMed
Article
CAS
Google Scholar
Kageyama R, Ohtsuka T, Kobayashi T (2008) Roles of Hes genes in neural development. Dev Growth Differ 50:S97–S103
PubMed
Article
CAS
Google Scholar
Kang J, Gocke CB, Yu H (2006) Phosphorylation-facilitated sumoylation of MEF2C negatively regulates its transcriptional activity. BMC Biochem 7:5
PubMed
Article
Google Scholar
Kim CE, Perez A, Perkins G, Ellisman MH, Dauer WT (2010) A molecular mechanism underlying the neural-specific defect in torsinA mutant mice. Proc Natl Acad Sci USA 107(21):9861–9866
PubMed
Article
CAS
Google Scholar
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227(5259):680–685
PubMed
Article
CAS
Google Scholar
Lee JE (1997) Basic helix-loop-helix genes in neural development. Curr Opin Neurobiol 7(1):13–20
PubMed
Article
Google Scholar
Li H, Radford JC, Ragusa MJ, Shea KL, McKercher SR, Zaremba JD, Soussou W, Nie Z, Kang Y-J, Nakanishi N, Okamoto S, Roberts AJ, Schwarz J, Lipton SA (2008) Transcription factor MEF2C influences neural stem/progenitor cell differentiation and maturation in vivo. Proc Natl Acad Sci USA 105(27):9397–9402
PubMed
Article
CAS
Google Scholar
Lin Q, Schwarz J, Bucana C, Olson EN (1997) Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science 276(5317):1404–1407
PubMed
Article
CAS
Google Scholar
Lin Q, Lu J, Yanagisawa H, Webb R, Lyons GE, Richardson JA, Olson EN (1998) Requirement of the MADS-box transcription factor MEF2C for vascular development. Development 125(22):4565–4574
PubMed
CAS
Google Scholar
Lyons GE, Micales BK, Schwarz J, Martin JF, Olson EN (1995) Expression of mef2 genes in the mouse central nervous system suggests a role in neuronal maturation. J Neurosci 15(8):5727–5738
PubMed
CAS
Google Scholar
Martin JF, Schwarz JJ, Olson EN (1993) Myocyte enhancer factor (MEF) 2C: a tissue-restricted member of the MEF-2 family of transcription factors. Proc Natl Acad Sci USA 90(11):5282–5286
PubMed
Article
CAS
Google Scholar
Menzies FM, Hourez R, Imarisio S, Raspe M, Sadiq O, Chandraratna D et al (2010) Puromycin-sensitive aminopeptidase protects against aggregation-prone proteins via autophagy. Hum Mol Genet 19(23):4573–4586
PubMed
Article
CAS
Google Scholar
Molkentin JD, Olson EN (1996) Combinatorial control of muscle development by basic helix-loop-helix and MADS-box transcription factors. Proc Natl Acad Sci USA 93(18):9366–9373
PubMed
Article
CAS
Google Scholar
Molkentin JD, Black BL, Martin JF, Olson EN (1995) Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell 83(7):1125–1136
PubMed
Article
CAS
Google Scholar
Molkentin JD, Black BL, Martin JF, Olson EN (1996) Mutational analysis of the DNA binding, dimerization, and transcriptional activation domains of MEF2C. Mol Cell Biol 16(6):2627–2636
PubMed
CAS
Google Scholar
Mori T, Wada T, Suzuki T, Kubota Y, Inagaki N (2007) Singar1, a novel RUN domain-containing protein, suppresses formation of surplus axons for neuronal polarity. J Biol Chem 282(27):19884–19893
PubMed
Article
CAS
Google Scholar
Naya FJ, Wu C, Richardson JA, Overbeek P, Olson EN (1999) Transcriptional activity of MEF2 during mouse embryogenesis monitored with a MEF2-dependent transgene. Development 126(10):2045–2052
PubMed
CAS
Google Scholar
New L, Han J (1998) The p38 MAP kinase pathway and its biological function. Trends Cardiovasc Med 8(5):220–228
PubMed
Article
CAS
Google Scholar
Novara F, Beri S, Giorda R, Ortibus E, Nageshappa S, Darra F, Bernardina BD, Zuffardi O, Van EH (2010) Refining the phenotype associated with MEF2C haplo insufficiency. Clin Genet 78(5):471–477
PubMed
Article
CAS
Google Scholar
Nowakowska BA, Obersztyn E, Szymańska K, Bekiesińska-Figatowska M, Xia Z, Ricks CB, Bocian E, Stockton DW, Szczałuba K, Nawara M, Patel A, Scott DA, Cheung SW, Bohan TP, Stankiewicz P (2010) Severe mental retardation, seizures, and hypotonia due to deletions of MEF2C. Am J Med Genet B 153B(5):1042–1051
CAS
Google Scholar
Okamoto S, Krainc D, Sherman K, Lipton SA (2000) Antiapoptotic role of the p38 mitogen-activated protein kinase-myocyte enhancer factor 2 transcription factor pathway during neuronal differentiation. Proc Natl Acad Sci USA 97(13):7561–7566
PubMed
Article
CAS
Google Scholar
Osada T, Ikegami S, Takiguchi-Hayashi K, Yamazaki Y, Katoh-Fukui Y, Higashinakagawa T et al (1999) Increased anxiety and impaired pain response in puromycin-sensitive aminopeptidase gene-deficient mice obtained by a mouse gene-trap method. J Neurosci 19(14):6068–6078
PubMed
CAS
Google Scholar
Potthoff MJ, Arnold MA, McAnally J, Richardson JA, Bassel-Duby R, Olson EN (2007) Regulation of skeletal muscle sarcomere integrity and postnatal muscle function by Mef2c. Mol Cell Biol 27(23):8143–8151
PubMed
Article
CAS
Google Scholar
Ridgeway AG, Wilton S, Skerjanc IS (2000) Myocyte enhancer factor 2C and myogenin up-regulate each others expression and induce the development of skeletal muscle in P19 cells. J Biol Chem 275(1):41–46
PubMed
Article
CAS
Google Scholar
Shore P, Sharrocks AD (1995) The MADS-box family of transcription factors. Eur J Biochem 229(1):1–13
PubMed
Article
CAS
Google Scholar
Skerjanc IS, Wilton S (2000) Myocyte enhancer factor 2C upregulates MASH-1 expression and induces neurogenesis in P19 cells. FEBS Lett 472(1):53–56
PubMed
Article
CAS
Google Scholar
Smyth GK (2004) Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3(1):article 3
Vanpoucke G, Goossens S, De Craene B, Gilbert B, Roy FV, Berx G (2004) GATA-4 and MEF2C transcription factors control the tissue-specific expression of the alphaT-catenin gene CTNNA3. Nucleic Acids Res 32(14):4155–4165
PubMed
Article
CAS
Google Scholar
Verzi MP, Agarwal P, Brown C, McCulley DJ, Schwarz JJ, Black BL (2007) The transcription factor MEF2C is required for craniofacial development. Dev Cell 12(4):645–652
PubMed
Article
CAS
Google Scholar
Wang DZ, Valdez MR, McAnally J, Richardson JA, Olson EN (2001) The Mef2c gene is a direct transcriptional target of myogenic bHLH and MEF2 proteins during skeletal muscle development. Development 128(22):4623–4633
PubMed
CAS
Google Scholar
Zhu B, Gulick T (2004) Phosphorylation and alternative pre-mRNA splicing converge to regulate myocyte enhancer factor 2C activity. Mol Cell Biol 24(18):8264–8275
PubMed
Article
CAS
Google Scholar
Zhu B, Ramachandran B, Gulick T (2005) Alternative pre-mRNA splicing governs expression of a conserved acidic transactivation domain in myocyte enhancer factor 2 factors of striated muscle and brain. J Biol Chem 280(31):28749–28760
PubMed
Article
CAS
Google Scholar
Zweier M, Gregor A, Zweier C, Engels H, Sticht H, Wohlleber E, Bijlsma EK, Holder SE, Zenker M, Rossier E, Grasshoff U, Johnson DS, Robertson L, Firth HV, Ekici AB, Reis A, Rauch A (2010) Mutations in MEF2C from the 5q143q15 microdeletion syndrome region are a frequent cause of severe mental retardation and diminish MECP2 and CDKL5 expression. Hum Mutat 31(6):722–733
PubMed
Article
CAS
Google Scholar